Winton Ventures

Winton Ventures is the venture capital arm of Winton Group, the London-headquartered quantitative investment management firm founded in 1997 by British billionaire Sir David Winton Harding and now managing approximately $13 billion in assets across systematic strategies, with offices in London, Shanghai, Abu Dhabi, New York, Hong Kong and Sydney. Winton Ventures was established in 2015 to leverage the parent group's deep in-house expertise in data science, statistical analysis and computational research as a structural advantage when investing in technology companies. The unit's thesis focuses on entrepreneurs creating breakthroughs in data-rich and data-intensive verticals, cybersecurity, energy and environment, including transformational deep-tech like fusion, data science and applied analytics, and healthcare and biotech, generally as a co-investor. Across roughly 32 disclosed investments the portfolio includes BlueVoyant in cyber defence-as-a-service, Exonar in data discovery, OxSonics in medical ultrasound therapeutics, Panaseer in continuous controls monitoring, Ripjar in open-source data intelligence, Tessian in machine-learning email security, acquired by Proofpoint in 2024, and the high-profile fusion-energy company Tokamak Energy, which raised an additional $125 million in November 2024 to commercialize transformative fusion and high-temperature superconducting-magnet technologies. Winton Ventures pairs capital with operational data-science partnership from the broader Winton organization. Specific fund size and current named partner roster for the Ventures unit are not publicly disclosed. By drawing on its parent's quantitative and data-science expertise, Winton Ventures backs founders building breakthroughs in cybersecurity, energy, analytics and healthcare, with notable exposure to frontier deep-tech such as fusion energy.